Abstract
Inositol hexaphosphate (IP6, InsP6) is a polyphosphorylated carbohydrate with diverse signaling properties. IP6 is plentiful in organisms as diverse as yeast, actinobacteria, mammals and plants. In the plant kingdom, IP6 accumulates during seed development; during germination it is broken down into lower inositol phosphates and micronutrients to maintain seedling. IP6 is the most abundant of the intracellular inositol phosphates in eukaryotes. In mammals IP6 maintains homeostasis, stores phosphate and acts as a strong anti-oxidant and neurotransmitter. IP6’s rapid phosphate turnover properties justify its critical role in cellular pathways involved in signal transduction, control of cell proliferation and differentiation, RNA export, DNA repair, energy transduction and ATP regeneration. The health benefits of IP6 have been demonstrated to lower serum cholesterol level, normalize pathological platelet activity and prevent pathological calcification and kidney stone formation. It is also a potent antioxidant and immunity enhancer. However, it is the field of cancer prevention and therapy that may be the biggest career for IP6. In this review we present updated knowledge on signaling events caused by this fascinating, ubiquitous molecule that has numerous functions.
Keywords: IP6, inositol, phytate, polyphosphates, signal transduction, nutraceuticals, actinobacteria, myo-isoform, pentakisphosphate, Myxobacteria
Current Signal Transduction Therapy
Title:IP6 (Inositol Hexaphosphate) as a Signaling Molecule
Volume: 7 Issue: 3
Author(s): Abul Kalam Shamsuddin and Sanchita Bose
Affiliation:
Keywords: IP6, inositol, phytate, polyphosphates, signal transduction, nutraceuticals, actinobacteria, myo-isoform, pentakisphosphate, Myxobacteria
Abstract: Inositol hexaphosphate (IP6, InsP6) is a polyphosphorylated carbohydrate with diverse signaling properties. IP6 is plentiful in organisms as diverse as yeast, actinobacteria, mammals and plants. In the plant kingdom, IP6 accumulates during seed development; during germination it is broken down into lower inositol phosphates and micronutrients to maintain seedling. IP6 is the most abundant of the intracellular inositol phosphates in eukaryotes. In mammals IP6 maintains homeostasis, stores phosphate and acts as a strong anti-oxidant and neurotransmitter. IP6’s rapid phosphate turnover properties justify its critical role in cellular pathways involved in signal transduction, control of cell proliferation and differentiation, RNA export, DNA repair, energy transduction and ATP regeneration. The health benefits of IP6 have been demonstrated to lower serum cholesterol level, normalize pathological platelet activity and prevent pathological calcification and kidney stone formation. It is also a potent antioxidant and immunity enhancer. However, it is the field of cancer prevention and therapy that may be the biggest career for IP6. In this review we present updated knowledge on signaling events caused by this fascinating, ubiquitous molecule that has numerous functions.
Export Options
About this article
Cite this article as:
Kalam Shamsuddin Abul and Bose Sanchita, IP6 (Inositol Hexaphosphate) as a Signaling Molecule, Current Signal Transduction Therapy 2012; 7 (3) . https://dx.doi.org/10.2174/157436212802481628
DOI https://dx.doi.org/10.2174/157436212802481628 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Therapeutic Strategies of Regenerative Medicine for Renal Failure
Current Stem Cell Research & Therapy Overview of Medicinally Important Diterpenoids Derived from Plastids
Mini-Reviews in Medicinal Chemistry Chemokines and Atherosclerotic Plaque Progression: Towards Therapeutic Targeting?
Current Pharmaceutical Design Subject Index to Volume 2
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents New Insights into the Mechanisms Underlying Vascular and Cardiac Effects of Urocortin
Current Vascular Pharmacology Gender Based Differences in Stress-induced Gastric Ulcer Formation and its Regulation by Nitric Oxide (NO): An Experimental Study
Current Pharmaceutical Design Application of Decoy Oligodeoxynucleotides-Based Approach to Renal Diseases
Current Drug Targets Neuron Protection as a Therapeutic Target in Acute Ischemic Stroke
Current Topics in Medicinal Chemistry Statins and Ischaemia Reperfusion Injury: A Molecular Biological Review
Current Vascular Pharmacology Nicotinamide Adenine Dinucleotide Based Therapeutics
Current Medicinal Chemistry The role of NADPH Oxidase in Vascular Disease – Hypertension, Atherosclerosis & Stroke
Current Pharmaceutical Design Role of Free Radicals and Poly(ADP-Ribose)Polymerase-1 in the Development of Spinal Cord Injury: New Potential Therapeutic Targets
Current Medicinal Chemistry Biochemical Markers in the Prediction of Contrast-induced Acute Kidney Injury
Current Medicinal Chemistry Persistent Pulmonary Hypertension of the Newborn: Therapeutical Approach
Mini-Reviews in Medicinal Chemistry Stem Cell Therapy for the Treatment of Acute Myocardial Infarction and Chronic Ischemic Heart Disease
Current Pharmaceutical Biotechnology Neuroprotective Effects of a Glutathione Depletor in Rat Post-Ischemic Reperfusion Brain Damage
CNS & Neurological Disorders - Drug Targets Pharmacokinetic Analysis of Tetramethylpyrazine Bis-Nitrone TN-2 in Rats and its Protein Binding In Vitro
Letters in Drug Design & Discovery Low Level Laser Therapy [LLLT] in Inflammatory and Rheumatic Diseases:A Review of Therapeutic Mechanisms
Current Rheumatology Reviews Natural Product-Derived Small Molecule Activators of Hypoxia-Inducible Factor-1 (HIF-1)
Current Pharmaceutical Design Targeting Parkinson’s - Tyrosine Hydroxylase and Oxidative Stress as Points of Interventions
CNS & Neurological Disorders - Drug Targets